Official Publications Amgen Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 13/02/2026 GMT			5-day change	1st Jan Change
369.19 ^USD	+1.52%		-3.94%	+12.80%

02-12	Amgen Inc. Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium, Feb-12-2026 05:00 PM
02-12	European Commission approves Amgen's Uplizna® for generalized myasthenia gravis	RE

02-02	Slide show Q4	CO
02-02	Annual results	CO
02-02	SEC Filing 8K	CO
11-03	SEC Filing 10Q-3	CO
11-03	SEC Filing 8K	CO
11-03	Slide show Q3	CO
11-03	3rd quarter results	CO
05/08/25	SEC Filing 10Q-2	CO
04/08/25	1st-half-year results	CO
04/08/25	Slide show half-year results	CO
04/08/25	SEC Filing 8K	CO
22/05/25	Minutes of the general assembly	CO
30/04/25	Slide show Q1	CO
30/04/25	1st quarter results	CO
30/04/25	SEC Filing 10Q-1	CO
30/04/25	SEC Filing 8K	CO
08/04/25	Proxy Statments	CO
13/02/25	SEC Filing 10K	CO
03/02/25	SEC Filing 8K	CO
03/02/25	Slide show results	CO
03/02/25	Annual results	CO
29/10/24	SEC Filing 10Q-3	CO
29/10/24	Slide show Q3	CO
29/10/24	3rd quarter results	CO
29/10/24	SEC Filing 8K	CO